Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Fallopian Tube Neoplasms"" wg kryterium: Temat


Tytuł :
Challenges and management options of tubo-ovarian cancer in the midst of SARS-CoV-2 pandemic.
Autorzy :
Tranoulis A; Department of Gynaecological Oncology, Maidstone and Turnbridge Wells NHS Trust, UK. Electronic address: .
Georgiou D; Department of Gynaecology, Chelsea and Westminster NHS Trust, Imperial College, London, UK.
Pokaż więcej
Źródło :
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2020 Nov; Vol. 46 (11), pp. 2160-2161. Date of Electronic Publication: 2020 Jun 30.
Typ publikacji :
Letter
MeSH Terms :
Pandemics*/prevention & control
Coronavirus Infections/*epidemiology
Fallopian Tube Neoplasms/*surgery
Ovarian Neoplasms/*surgery
Pneumonia, Viral/*epidemiology
Betacoronavirus ; Coronavirus Infections/prevention & control ; Fallopian Tube Neoplasms/diagnosis ; Fallopian Tube Neoplasms/drug therapy ; Female ; Humans ; Ovarian Neoplasms/diagnosis ; Ovarian Neoplasms/drug therapy ; Patient Selection ; Pneumonia, Viral/prevention & control ; Practice Guidelines as Topic ; United Kingdom/epidemiology
SCR Disease Name :
COVID-19
Opinia redakcyjna
Tytuł :
[Efficacy of Olaparib Treatment for Platinum-Sensitive Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancers].
Autorzy :
Takei T; Dept. of Obstetrics and Gynecology, Kansai Rosai Hospital.
Takaki E
Tsuji S
Onoue M
Yamashita M
Yoshioka E
Goto M
Tashima L
Ito K
Hori K
Pokaż więcej
Źródło :
Gan to kagaku ryoho. Cancer & chemotherapy [Gan To Kagaku Ryoho] 2020 Oct; Vol. 47 (10), pp. 1457-1460.
Typ publikacji :
Journal Article
MeSH Terms :
Fallopian Tube Neoplasms*/drug therapy
Ovarian Neoplasms*/drug therapy
Fallopian Tubes ; Female ; Humans ; Neoplasm Recurrence, Local ; Phthalazines ; Piperazines ; Platinum
Czasopismo naukowe
Tytuł :
Suppressive effect upon carboplatin hypersensitivity reaction via pegylated liposomal doxorubicin combination therapy.
Autorzy :
Shimada K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Nagao S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan. .
Suzuki K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Shibutani T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Yamamoto K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Jimi T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Yano H; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Kitai M; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Shiozaki T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Yamaguchi S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-city, Hyogo, 673-8558, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2020 Sep; Vol. 25 (9), pp. 1718-1725. Date of Electronic Publication: 2020 May 23.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Carboplatin/*adverse effects
Fallopian Tube Neoplasms/*drug therapy
Ovarian Neoplasms/*drug therapy
Peritoneal Neoplasms/*drug therapy
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin/administration & dosage ; Doxorubicin/administration & dosage ; Doxorubicin/analogs & derivatives ; Fallopian Tube Neoplasms/mortality ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/mortality ; Peritoneal Neoplasms/mortality ; Polyethylene Glycols/administration & dosage ; Young Adult
Czasopismo naukowe
Tytuł :
Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study.
Autorzy :
Van Calster B; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.; EPI-Centre, KU Leuven, Leuven, Belgium.
Valentin L; Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Froyman W; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
Landolfo C; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
Ceusters J; Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.
Testa AC; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.; Department of Life Science and Public Health, Universita' Cattolica del Sacro Cuore, Rome, Italy.
Wynants L; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Epidemiology, CAPHRI Care and Public Health Research Institute, Maastricht University, Maastricht, Netherlands.
Sladkevicius P; Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Van Holsbeke C; Department of Obstetrics and Gynaecology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Domali E; First Department of Obstetrics and Gynaecology, Alexandra Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Fruscio R; Clinic of Obstetrics and Gynaecology, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy.
Epstein E; Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.; Department of Obstetrics and Gynaecology, Södersjukhuset, Stockholm, Sweden.
Franchi D; Preventive Gynaecology Unit, Division of Gynaecology, European Institute of Oncology IRCCS, Milan, Italy.
Kudla MJ; Department of Perinatology and Oncological Gynaecology, School of Health Sciences in Katowice, Medical University of Silesia, Katowice, Poland.
Chiappa V; Department of Gynaecologic Oncology, National Cancer Institute of Milan, Milan, Italy.
Alcazar JL; Department of Obstetrics and Gynaecology, Clinica Universidad de Navarra, School of Medicine, Pamplona, Spain.
Leone FPG; Department of Obstetrics and Gynaecology, Biomedical and Clinical Sciences Institute L. Sacco, University of Milan, Milan, Italy.
Buonomo F; Institute for Maternal and Child Health, IRCCS Burlo Garofolo, Trieste, Italy.
Coccia ME; Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy.
Guerriero S; Department of Obstetrics and Gynaecology, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Cagliari, Italy.
Deo N; Department of Obstetrics and Gynaecology, Whipps Cross Hospital, London, UK.
Jokubkiene L; Department of Obstetrics and Gynaecology, Skåne University Hospital, Malmö, Sweden.; Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.
Savelli L; Department of Obstetrics and Gynaecology, University of Bologna, Bologna, Italy.
Fischerová D; Gynaecological Oncology Centre, Department of Obstetrics and Gynaecology, First Faculty of Medicine, Charles University and General University Hospital, Prague, Czech Republic.
Czekierdowski A; First Department of Gynaecological Oncology and Gynaecology, Medical University of Lublin, Lublin, Poland.
Kaijser J; Department of Obstetrics and Gynaecology, Ikazia Hospital, Rotterdam, Netherlands.
Coosemans A; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.; Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Scambia G; Department of Woman, Child and Public Health, Fondazione Policlinico Universitario Agostino Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy.; Department of Life Science and Public Health, Universita' Cattolica del Sacro Cuore, Rome, Italy.
Vergote I; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.; Laboratory of Tumour Immunology and Immunotherapy, Department of Oncology, KU Leuven, Leuven, Belgium.; Leuven Cancer Institute, University Hospitals Leuven, Leuven, Belgium.
Bourne T; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium.; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.; Queen Charlotte's and Chelsea Hospital, Imperial College, London, UK.
Timmerman D; Department of Development and Regeneration, KU Leuven, Herestraat 49 Box 805, 3000 Leuven, Belgium .; Department of Obstetrics and Gynaecology, University Hospitals Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
BMJ (Clinical research ed.) [BMJ] 2020 Jul 30; Vol. 370, pp. m2614. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't; Validation Study
MeSH Terms :
Logistic Models*
Fallopian Tube Neoplasms/*diagnosis
Fallopian Tube Neoplasms/*pathology
Ovarian Neoplasms/*diagnosis
Ovarian Neoplasms/*pathology
Adolescent ; Adult ; Aged ; Aged, 80 and over ; CA-125 Antigen/blood ; Calibration ; Conservative Treatment ; Fallopian Tube Neoplasms/therapy ; Female ; Humans ; Membrane Proteins/blood ; Middle Aged ; Ovarian Neoplasms/therapy ; Ovariectomy ; Prospective Studies ; Risk Assessment/methods ; Ultrasonography ; Young Adult
Czasopismo naukowe
Tytuł :
Reduced PAX2 expression in murine fallopian tube cells enhances estrogen receptor signaling.
Autorzy :
Colina JA; Pharmaceutical Sciences, Center for Biomolecular Science, University of Illinois at Chicago, Chicago, IL, USA.
Varughese P; Pharmaceutical Sciences, Center for Biomolecular Science, University of Illinois at Chicago, Chicago, IL, USA.
Karthikeyan S; Pharmaceutical Sciences, Center for Biomolecular Science, University of Illinois at Chicago, Chicago, IL, USA.
Salvi A; Pharmaceutical Sciences, Center for Biomolecular Science, University of Illinois at Chicago, Chicago, IL, USA.
Modi DA; Pharmaceutical Sciences, Center for Biomolecular Science, University of Illinois at Chicago, Chicago, IL, USA.
Burdette JE; Pharmaceutical Sciences, Center for Biomolecular Science, University of Illinois at Chicago, Chicago, IL, USA.
Pokaż więcej
Źródło :
Carcinogenesis [Carcinogenesis] 2020 Jul 10; Vol. 41 (5), pp. 646-655.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Epithelium/*pathology
Estrogens/*metabolism
Fallopian Tube Neoplasms/*pathology
Fallopian Tubes/*pathology
PAX2 Transcription Factor/*antagonists & inhibitors
Receptors, Estrogen/*metabolism
Animals ; Antineoplastic Agents/pharmacology ; Apoptosis ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Cell Cycle ; Cell Movement ; Cell Proliferation ; Disease Models, Animal ; Epithelium/drug effects ; Epithelium/metabolism ; Fallopian Tube Neoplasms/drug therapy ; Fallopian Tube Neoplasms/genetics ; Fallopian Tube Neoplasms/metabolism ; Fallopian Tubes/drug effects ; Fallopian Tubes/metabolism ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; PAX2 Transcription Factor/genetics ; PAX2 Transcription Factor/metabolism ; Receptors, Estrogen/genetics ; Signal Transduction ; Transcriptome ; Tumor Cells, Cultured
Czasopismo naukowe
Tytuł :
Incidental occurrence of high grade serous tubal adenocarcinoma after prophylactic adnexectomy in benign gynecological surgery.
Autorzy :
Kozolková D
Spodniaková B
Hajduková M
Hollý I
Záhumenský J
Pokaż więcej
Transliterated Title :
Náhodný výskyt high grade serózneho adenokarcinómu tuby v rámci profylaktickej adnexektómie pri benígnej gynekologickej operácii.
Źródło :
Ceska gynekologie [Ceska Gynekol] 2020 Winter; Vol. 85 (2), pp. 111-115.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Prophylactic Surgical Procedures*
Adenocarcinoma/*surgery
Adnexal Diseases/*surgery
Fallopian Tube Neoplasms/*surgery
Gynecologic Surgical Procedures/*methods
Adenocarcinoma/pathology ; Adnexal Diseases/pathology ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Hysterectomy, Vaginal ; Incidental Findings ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/surgery ; Salpingectomy ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Embryonal Rhabdomyosarcoma of the Ovary and Fallopian Tube: Rare Neoplasms Associated With Germline and Somatic DICER1 Mutations.
Autorzy :
McCluggage WG; Department of Pathology, Belfast Health and Social Care Trust, Belfast, Northern Ireland.
Apellaniz-Ruiz M; Department of Human Genetics, McGill University.; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.
Chong AL; Department of Human Genetics, McGill University.; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.
Hanley KZ; Department of Pathology, and Laboratory Medicine, Emory University Hospital.
Velázquez Vega JE; Department of Pathology and Laboratory Medicine, Children's Healthcare of Atlanta and Emory University, Atlanta, GA.
McVeigh TP; Cancer Genetics Unit, Royal Marsden NHS Foundation Trust, London, United Kingdom.
Foulkes WD; Department of Human Genetics, McGill University.; Cancer Axis, Lady Davis Institute, Jewish General Hospital, Montréal, QC, Canada.
Pokaż więcej
Źródło :
The American journal of surgical pathology [Am J Surg Pathol] 2020 Jun; Vol. 44 (6), pp. 738-747.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
DEAD-box RNA Helicases/*genetics
Fallopian Tube Neoplasms/*genetics
Neoplastic Syndromes, Hereditary/*genetics
Ovarian Neoplasms/*genetics
Rhabdomyosarcoma, Embryonal/*genetics
Ribonuclease III/*genetics
Adolescent ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Mutation ; Ovarian Neoplasms/pathology ; Rhabdomyosarcoma, Embryonal/pathology
Czasopismo naukowe
Tytuł :
Primary transitional cell carcinoma of the fallopian tube: A case report and literature review.
Autorzy :
Lee DH; Department of Obstetrics and Gynecology, Jeonbuk National University Hospital-Jeonbuk National University Medical School.; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.
Cho DH; Department of Obstetrics and Gynecology, Jeonbuk National University Hospital-Jeonbuk National University Medical School.; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.
Kim KM; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.; Department of Pathology.
Yim CY; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.; Division of Hematology and oncology, Department of Internal Medicine, Jeonbuk National University Hospital-Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Lee NR; Research Institute of Clinical Medicine of Jeonbuk National University-Biomedical Research Institute of Jeonbuk National University Hospital.; Division of Hematology and oncology, Department of Internal Medicine, Jeonbuk National University Hospital-Jeonbuk National University Medical School, Jeonju, Republic of Korea.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2020 May 29; Vol. 99 (22), pp. e20499.
Typ publikacji :
Case Reports; Journal Article; Review
MeSH Terms :
Carcinoma, Transitional Cell/*diagnostic imaging
Carcinoma, Transitional Cell/*surgery
Fallopian Tube Neoplasms/*diagnostic imaging
Fallopian Tube Neoplasms/*surgery
Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carcinoma, Transitional Cell/pathology ; Cisplatin/therapeutic use ; Deoxycytidine/analogs & derivatives ; Deoxycytidine/therapeutic use ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Hysterectomy ; Magnetic Resonance Imaging ; Neoplasm Recurrence, Local/drug therapy ; Palliative Care ; Salpingo-oophorectomy
Czasopismo naukowe
Tytuł :
Outcomes in Advanced Stage Epithelial Ovarian, Fallopian Tubal, and Peritoneal Cancer after Primary Surgery and Adjuvant Chemotherapies: A Single-Institute Real-World Experience.
Autorzy :
Chang CH; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Kuo HL; Department of Nursing, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Chen TC; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Weng CS; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Lim L; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Huang WC; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Chang CL; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Su TH; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Hsinchu Branch, Hsinchu 30071, Taiwan.
Wang KG; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Wang KL; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taitung Branch, Taitung 95054, Taiwan.; Department of General Education, MacKay Junior College of Medicine, Nursing and Management, New Taipei City 11260, Taiwan.
Yang YC; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.
Chen JR; Department of Obstetric & Gynecology, MacKay Memorial Hospital, Taipei 10449, Taiwan.; Department of General Education, MacKay Junior College of Medicine, Nursing and Management, New Taipei City 11260, Taiwan.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 May 18; Vol. 17 (10). Date of Electronic Publication: 2020 May 18.
Typ publikacji :
Journal Article
MeSH Terms :
Chemotherapy, Adjuvant*
Fallopian Tube Neoplasms*/drug therapy
Fallopian Tube Neoplasms*/surgery
Ovarian Neoplasms*/drug therapy
Ovarian Neoplasms*/surgery
Peritoneal Neoplasms*/drug therapy
Peritoneal Neoplasms*/surgery
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Female ; Humans ; Middle Aged ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Pathologic findings and clinical outcomes in women undergoing risk-reducing surgery to prevent ovarian and fallopian tube carcinoma: A large prospective single institution experience.
Autorzy :
Rush SK; Department of Obstetrics & Gynecology, University of Washington Medical Center, United States of America.
Swisher EM; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Washington Medical Center, United States of America.
Garcia RL; Department of Pathology, University of Washington Medical Center, United States of America.
Pennington KP; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Washington Medical Center, United States of America.
Agnew KJ; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Washington Medical Center, United States of America.
Kilgore MR; Department of Pathology, University of Washington Medical Center, United States of America.
Norquist BM; Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Washington Medical Center, United States of America. Electronic address: .
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2020 May; Vol. 157 (2), pp. 514-520. Date of Electronic Publication: 2020 Mar 19.
Typ publikacji :
Journal Article; Observational Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Fallopian Tube Neoplasms/*prevention & control
Fallopian Tubes/*surgery
Ovarian Neoplasms/*prevention & control
Ovary/*surgery
Adult ; Aged ; BRCA2 Protein/genetics ; Cohort Studies ; Fallopian Tube Neoplasms/genetics ; Fallopian Tube Neoplasms/pathology ; Fanconi Anemia Complementation Group N Protein/genetics ; Female ; Genetic Predisposition to Disease ; Humans ; Middle Aged ; Mutation ; Neoplasms, Unknown Primary/diagnosis ; Neoplasms, Unknown Primary/pathology ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Pedigree ; Prospective Studies ; Salpingo-oophorectomy ; Ubiquitin-Protein Ligases/genetics
Czasopismo naukowe
Tytuł :
Dose-dense paclitaxel and carboplatin vs. conventional paclitaxel and carboplatin as neoadjuvant chemotherapy for advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer: a retrospective study.
Autorzy :
Shibutani T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Nagao S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan. .
Suzuki K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Kaneda M; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Yamamoto K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Jimi T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Yano H; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Kitai M; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Shiozaki T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Matsuoka K; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Sudo T; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Yamaguchi S; Department of Gynecologic Oncology, Hyogo Cancer Center, 13-70 Kitaoji-cho, Akashi-City, 673-8558, Hyogo, Japan.
Pokaż więcej
Źródło :
International journal of clinical oncology [Int J Clin Oncol] 2020 Mar; Vol. 25 (3), pp. 502-507. Date of Electronic Publication: 2019 Nov 01.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Carcinoma, Ovarian Epithelial/*drug therapy
Fallopian Tube Neoplasms/*drug therapy
Peritoneal Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Carboplatin/administration & dosage ; Carcinoma, Ovarian Epithelial/mortality ; Carcinoma, Ovarian Epithelial/surgery ; Cytoreduction Surgical Procedures ; Fallopian Tube Neoplasms/mortality ; Fallopian Tube Neoplasms/surgery ; Female ; Humans ; Middle Aged ; Multivariate Analysis ; Neoadjuvant Therapy ; Paclitaxel/administration & dosage ; Peritoneal Neoplasms/mortality ; Peritoneal Neoplasms/surgery ; Progression-Free Survival ; Proportional Hazards Models ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Prognostic value of serum HE4 in patients with advanced ovarian, fallopian tube, and peritoneal carcinoma.
Autorzy :
Mi D; Department of Clinical Laboratory, Tianjin Central Hospital of Obstetrics and Gynecology, No. 156, Nankai Three Road, Tianjin, China. .
Zhang Y; Department of Clinical Laboratory, Tianjin Central Hospital of Obstetrics and Gynecology, No. 156, Nankai Three Road, Tianjin, China.
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Mar; Vol. 301 (3), pp. 779-785. Date of Electronic Publication: 2020 Feb 08.
Typ publikacji :
Journal Article
MeSH Terms :
Biomarkers, Tumor/*blood
Fallopian Tube Neoplasms/*blood
Ovarian Neoplasms/*blood
Peritoneal Neoplasms/*blood
WAP Four-Disulfide Core Domain Protein 2/*genetics
Adult ; Aged ; Fallopian Tube Neoplasms/mortality ; Fallopian Tube Neoplasms/pathology ; Female ; Humans ; Middle Aged ; Ovarian Neoplasms/mortality ; Ovarian Neoplasms/pathology ; Peritoneal Neoplasms/mortality ; Peritoneal Neoplasms/pathology ; Prognosis ; Survival Analysis
Czasopismo naukowe
Tytuł :
Comparisons of Clinical Outcomes in Women with Advanced Ovarian Cancer Treated with Frontline Intraperitoneal versus Dose-Dense Platinum/Paclitaxel Chemotherapy without Bevacizumab.
Autorzy :
Ting WH; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Hsiao CH; Division of Medical Oncology and Hematology, Department of Internal Medicine, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Chen HH; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Wei MC; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.
Lin HH; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.; Department of Obstetrics and Gynecology, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei 100225, Taiwan.
Hsiao SM; Department of Obstetrics and Gynecology, Far Eastern Memorial Hospital, New Taipei 220409, Taiwan.; Department of Obstetrics and Gynecology, National Taiwan University College of Medicine and National Taiwan University Hospital, Taipei 100225, Taiwan.; Graduate School of Biotechnology and Bioengineering, Yuan Ze University, Taoyuan 320315, Taiwan.
Pokaż więcej
Źródło :
International journal of environmental research and public health [Int J Environ Res Public Health] 2020 May 20; Vol. 17 (10). Date of Electronic Publication: 2020 May 20.
Typ publikacji :
Journal Article
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols*/therapeutic use
Fallopian Tube Neoplasms*/drug therapy
Ovarian Neoplasms*/drug therapy
Bevacizumab/administration & dosage ; Carboplatin ; Disease-Free Survival ; Female ; Humans ; Infusions, Parenteral ; Middle Aged ; Paclitaxel/administration & dosage ; Platinum/administration & dosage
Czasopismo naukowe
Tytuł :
Anterior mediastinal metastasis of primary fallopian tube adenocarcinoma: a case report.
Autorzy :
Zhang B; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Liu R; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Li T; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Chen F; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Huo H; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.
Ren D; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Ren F; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Xu S; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China.; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China.
Xu X; Colleges of Nursing, Tianjin Medical University, Qixiangtai Road No.22, Tianjin, 300070, China. .
Song Z; Department of Lung Cancer Surgery, Tianjin Medical University General Hospital, Anshan Road No 154, Heping District, Tianjin, 300052, China. .; Department of Lung Cancer Surgery; Tianjin key laboratory of lung cancer metastasis and tumor microenvironment, Tianjin Lung Cancer Institute, Tianjin Medical University General Hospital, Anshan Road No.154, Heping District, Tianjin, 300052, China. .
Pokaż więcej
Źródło :
Journal of cardiothoracic surgery [J Cardiothorac Surg] 2020 May 11; Vol. 15 (1), pp. 77. Date of Electronic Publication: 2020 May 11.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Adenocarcinoma/*pathology
Fallopian Tube Neoplasms/*pathology
Mediastinal Neoplasms/*secondary
Mediastinum/*pathology
Neoplasm Recurrence, Local/*surgery
Adenocarcinoma/surgery ; Aged ; Fallopian Tube Neoplasms/surgery ; Fallopian Tubes ; Female ; Humans ; Incidence ; Mediastinal Neoplasms/surgery
Czasopismo naukowe
Tytuł :
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial.
Autorzy :
Pfisterer J; Gynaecologic Oncology Center, Kiel, Germany. Electronic address: .
Shannon CM; Oncology Department, Mater Cancer Care Centre, Brisbane, QLD, Australia.
Baumann K; Gynaecology Department, Klinikum der Stadt Ludwigshafen am Rhein, Ludwigshafen, Germany.
Rau J; Coordinating Center for Clinical Trials, Philipps-University, Marburg, Germany.
Harter P; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany.
Joly F; Gynaecology Department, Centre François Baclesse, Caen, France.
Sehouli J; Department of Gynaecology, and European Competence Center for Ovarian Cancer, Charité - Universitätsmedizin Berlin, Campus Virchow, Berlin, Germany.
Canzler U; Department of Gynaecology, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Schmalfeldt B; Technical University of Munich-Klinikum Rechts der Isar, Germany; Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Dean AP; Gynaecological Oncology Department, St John of God Hospital, Subiaco, WA, Australia.
Hein A; Gynaecology Department, Erlangen University Hospital, Erlangen, Germany.
Zeimet AG; Department of Obstetrics and Gynaecology, Innsbruck Medical University, Innsbruck, Austria.
Hanker LC; Gynaecology Department, University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.
Petit T; Paul Strauss Cancer Center and Gynaecology Department, University of Strasbourg, Strasbourg, France.
Marmé F; Gynaecology Department, National Center for Tumor Disease, University of Heidelberg, Heidelberg, Germany; Department of Gynaecology and Obstetrics, University Hospital Mannheim, Mannheim, Germany.
El-Balat A; Department of Gynaecology and Obstetrics, University of Frankfurt/Main, Frankfurt, Germany.
Glasspool R; National Cancer Research Institute, Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, UK.
de Gregorio N; Department of Obstetrics and Gynaecology, University of Ulm, Ulm, Germany.
Mahner S; Department of Gynaecology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Obstetrics and Gynaecology, University Hospital, Ludwig-Maximilian-University, Munich, Germany.
Meniawy TM; Department of Medical Oncology, Sir Charles Gairdner Hospital, Perth, WA, Australia.
Park-Simon TW; Department of Gynaecology and Obstetrics, Medical University Hannover, Hannover, Germany.
Mouret-Reynier MA; Department of Medical Oncology, Centre Jean Perrin, Clermont-Ferrand, France.
Costan C; Department of Oncology, Hôpital Michallon, Grenoble, France.
Meier W; Department of Gynaecology and Obstetrics, Evangelisches Krankenhaus Düsseldorf, Germany; Department of Gynaecology and Obstetrics, University Hospital Düsseldorf, Düsseldorf, Germany.
Reinthaller A; Department of Gynecology and Gynecologic Oncology, Comprehensive Cancer Centre, University Hospital for Gynaecology, Medical University Vienna, Vienna, Austria.
Goh JC; Royal Brisbane & Women's Hospital, Brisbane, QLD, Australia.
L'Haridon T; Centre Hospitalier Départemental les Oudairies, La Roche-Sur-Yon, France.
Baron Hay S; Women's Health, Royal North Shore Hospital, Sydney, NSW, Australia.
Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany.
du Bois A; Department of Gynecology and Gynecological Oncology, Kliniken Essen-Mitte, Essen, Germany.
Kurtz JE; Haematology-Oncology Department, Centre Hospitalier Régional et Universitaire de Strasbourg Hôpital Civil, Strasbourg, France.
Pokaż więcej
Corporate Authors :
AGO-OVAR 2.21/ENGOT-ov 18 Investigators
Źródło :
The Lancet. Oncology [Lancet Oncol] 2020 May; Vol. 21 (5), pp. 699-709. Date of Electronic Publication: 2020 Apr 16.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*administration & dosage
Bevacizumab/*administration & dosage
Fallopian Tube Neoplasms/*drug therapy
Neoplasm Recurrence, Local/*drug therapy
Ovarian Neoplasms/*drug therapy
Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Australia/epidemiology ; Austria/epidemiology ; Bevacizumab/adverse effects ; Carboplatin/administration & dosage ; Carboplatin/adverse effects ; Doxorubicin/administration & dosage ; Doxorubicin/analogs & derivatives ; Fallopian Tube Neoplasms/pathology ; Female ; France/epidemiology ; Humans ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Ovarian Neoplasms/pathology ; Paclitaxel/administration & dosage ; Paclitaxel/adverse effects ; Platinum/administration & dosage ; Platinum/adverse effects ; Polyethylene Glycols/administration & dosage
Czasopismo naukowe
Tytuł :
Comparison of survival between primary debulking surgery and neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers in phase III randomised trial.
Autorzy :
Onda T; Department of Gynecology, Kitasato University School of Medicine, Sagamihara, Japan. Electronic address: .
Satoh T; Department of Obstetrics and Gynecology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Ogawa G; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Saito T; Gynecology Service, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
Kasamatsu T; Department of Gynecologic Oncology, National Cancer Center Hospital, Tokyo, Japan.
Nakanishi T; Department of Gynecologic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
Mizutani T; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Takehara K; Department of Gynecologic Oncology, National Hospital Organization Shikoku Cancer Center, Matsuyama, Japan.
Okamoto A; Department of Obstetrics and Gynecology, The Jikei University School of Medicine, Tokyo, Japan.
Ushijima K; Department of Obstetrics and Gynecology, Kurume University School of Medicine, Kurume, Japan.
Kobayashi H; Department of Gynecology and Obstetrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Kawana K; Department of Obstetrics and Gynecology, Faculty of Medicine, The University of Tokyo, Tokyo, Japan.
Yokota H; Department of Gynecology, Saitama Cancer Center, Kita Adachi Gun, Japan.
Takano M; Department of Clinical Oncology, National Defense Medical College Hospital, Tokorozawa, Japan.
Kanao H; Department of Gynecological Oncology, Cancer Institute Hospital, Tokyo, Japan.
Watanabe Y; Department of Obstetrics and Gynecology, Kindai University Faculty of Medicine, Osakasayama, Japan.
Yamamoto K; Department of Obstetrics and Gynecology, Faculty of Medicine, Kindai University, Sakai Hospital, Sakai, Japan.
Yaegashi N; Department of Obstetrics and Gynecology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kamura T; Medical Care Education Research Foundation, Yanagawa Hospital, Yanagawa, Japan.
Yoshikawa H; Ibaraki Prefectural Central Hospital, Kasama, Japan.
Pokaż więcej
Corporate Authors :
Japan Clinical Oncology Group
Źródło :
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2020 May; Vol. 130, pp. 114-125. Date of Electronic Publication: 2020 Mar 13.
Typ publikacji :
Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Carcinoma, Ovarian Epithelial/*surgery
Cytoreduction Surgical Procedures/*methods
Fallopian Tube Neoplasms/*surgery
Neoadjuvant Therapy/*methods
Peritoneal Neoplasms/*surgery
Adult ; Aged ; Carcinoma, Ovarian Epithelial/mortality ; Fallopian Tube Neoplasms/mortality ; Female ; Humans ; Middle Aged ; Neoplasm Staging ; Peritoneal Neoplasms/mortality
Czasopismo naukowe
Tytuł :
Clinical relevance of circulating tumor cells in ovarian, fallopian tube and peritoneal cancer.
Autorzy :
Banys-Paluchowski M; Department of Gynecology and Obstetrics, Asklepios Klinik Barmbek, Rübenkamp 220, 22307, Hamburg, Germany.
Fehm T; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Neubauer H; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Paluchowski P; Department of Gynecology and Obstetrics, Regio Klinik Pinneberg, Fahltskamp 74, 25421, Pinneberg, Germany.
Krawczyk N; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Meier-Stiegen F; Department of Obstetrics and Gynecology, Heinrich-Heine-University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Wallach C; Department of Gynecology and Obstetrics, Regio Klinik Pinneberg, Fahltskamp 74, 25421, Pinneberg, Germany.
Kaczerowsky A; Department of Gynecology and Obstetrics, Marienkrankenhaus Hamburg, Alfredstr. 9, 22087, Hamburg, Germany.
Gebauer G; Department of Gynecology and Obstetrics, Asklepios Klinik Barmbek, Rübenkamp 220, 22307, Hamburg, Germany. .
Pokaż więcej
Źródło :
Archives of gynecology and obstetrics [Arch Gynecol Obstet] 2020 Apr; Vol. 301 (4), pp. 1027-1035. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Biomarkers, Tumor/*blood
Fallopian Tube Neoplasms/*physiopathology
Neoplastic Cells, Circulating/*pathology
Ovarian Neoplasms/*physiopathology
Peritoneal Neoplasms/*physiopathology
Fallopian Tube Neoplasms/mortality ; Female ; Humans ; Ovarian Neoplasms/mortality ; Peritoneal Neoplasms/mortality ; Prognosis ; Prospective Studies ; Survival Analysis
Czasopismo naukowe
Tytuł :
Cytological sampling of fallopian tubes using a hysteroscopic catheter: A multi-center study.
Autorzy :
Powell CB; Kaiser Permanente Northern California Gynecologic Cancer Program, San Francisco, CA, United States of America; Kaiser Permanente Division of Research, Oakland, CA, United States of America. Electronic address: .
Littell RD; Kaiser Permanente Northern California Gynecologic Cancer Program, San Francisco, CA, United States of America.
Landen CN Jr; Department of Obstetrics and Gynecology, University of Virginia, Charlottesville, VA, United States of America.
Pramanik S; Santa Clara Valley Medical Center, San Jose, CA, United States of America.
Hamilton IC; Kaiser Permanente Division of Research, Oakland, CA, United States of America.
Suh-Burgmann EJ; Kaiser Permanente Division of Research, Oakland, CA, United States of America; Kaiser Permanente Northern California Gynecologic Oncology Program, Walnut Creek, CA, United States of America.
Pokaż więcej
Źródło :
Gynecologic oncology [Gynecol Oncol] 2020 Mar; Vol. 156 (3), pp. 636-640. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Catheterization/*instrumentation
Fallopian Tube Neoplasms/*pathology
Fallopian Tubes/*cytology
Hysteroscopy/*instrumentation
Catheterization/methods ; Cytodiagnosis/instrumentation ; Cytodiagnosis/methods ; Diagnosis, Differential ; Fallopian Tube Neoplasms/diagnosis ; Fallopian Tubes/pathology ; Feasibility Studies ; Female ; Genes, BRCA1 ; Genes, BRCA2 ; Germ-Line Mutation ; Humans ; Hysteroscopy/methods ; Middle Aged ; Neoplasm Staging ; Ovarian Neoplasms/genetics ; Ovarian Neoplasms/pathology ; Ovarian Neoplasms/prevention & control ; Ovarian Neoplasms/surgery ; Pilot Projects ; Salpingo-oophorectomy
Czasopismo naukowe
Tytuł :
Evidence for a Novel Endometrioid Carcinogenic Sequence in the Fallopian Tube With Unique Beta-Catenin Expression.
Autorzy :
Brouwer J; Department of Obstetrics and Gynecology, University Medical Center Gronigen, University of Gronigen, Groningen, The Netherlands (J.B., M.J.M.) Department of Pathology, Duke University Medical Center, Durham, North Carolina (K.C.S.) Jackson Laboratory for Genomic Medicine, Farmington, Connecticut (G.N.) Department of Pathology, Brigham and Women's Hospital (C.B.S., D.L.K., M.R.N., C.P.C.) Department of Pathology, Beth Israel Deaconess Hospital (J.H.), Boston, Massachusetts Institute of Molecular Medicine, University of Texas Health Sciences Center, Houston, Texas (W.X.).
Strickland KC
Ning G
Schmelkin CB
Kolin DL
Hecht J
Nucci MR
Mourits MJ
Xian W
Crum CP
Pokaż więcej
Źródło :
International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists [Int J Gynecol Pathol] 2020 Mar; Vol. 39 (2), pp. 163-169.
Typ publikacji :
Journal Article
MeSH Terms :
Carcinogenesis/*pathology
Carcinoma, Endometrioid/*pathology
Fallopian Tube Neoplasms/*pathology
Precancerous Conditions/*pathology
beta Catenin/*metabolism
Carcinogenesis/metabolism ; Carcinoma, Endometrioid/metabolism ; Fallopian Tube Neoplasms/metabolism ; Fallopian Tubes/metabolism ; Fallopian Tubes/pathology ; Female ; Humans ; Middle Aged ; Precancerous Conditions/metabolism
Czasopismo naukowe
Tytuł :
Murine Oviductal High-Grade Serous Carcinomas Mirror the Genomic Alterations, Gene Expression Profiles, and Immune Microenvironment of Their Human Counterparts.
Autorzy :
McCool KW; Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan.
Freeman ZT; Unit for Laboratory Animal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.
Zhai Y; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Wu R; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Hu K; Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan.
Liu CJ; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Tomlins SA; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.
Fearon ER; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Magnuson B; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Kuick R; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan.; Department of Biostatistics, University of Michigan School of Public Health, Ann Arbor, Michigan.
Cho KR; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan .; Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan.; Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
Pokaż więcej
Źródło :
Cancer research [Cancer Res] 2020 Feb 15; Vol. 80 (4), pp. 877-889. Date of Electronic Publication: 2019 Dec 05.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Cystadenocarcinoma, Serous/*genetics
Fallopian Tube Neoplasms/*genetics
Neurofibromin 1/*genetics
Ovarian Neoplasms/*genetics
Tumor Microenvironment/*immunology
Animals ; Carcinoma, Endometrioid/genetics ; Carcinoma, Endometrioid/immunology ; Carcinoma, Endometrioid/pathology ; Cystadenocarcinoma, Serous/immunology ; Cystadenocarcinoma, Serous/pathology ; Disease Models, Animal ; Fallopian Tube Neoplasms/immunology ; Fallopian Tube Neoplasms/pathology ; Fallopian Tubes/pathology ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Mice ; Mice, Transgenic ; Myeloid-Derived Suppressor Cells/immunology ; Ovarian Neoplasms/immunology ; RNA-Seq ; T-Lymphocytes, Regulatory/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies